The $2 Trillion COVID-19 Stimulus Law and Its Impact on the Health Care Industry
Webinar | 04.01.20, 12:00 PM EDT - 1:00 PM EDT
On Friday, Congress passed the COVID-19 Stimulus Law in its most recent installment of critical legislation responding to the COVID-19 pandemic. As expected, the legislation includes a number of health care provisions aimed at addressing emergency drug and device shortages; increasing access to care for patients with COVID-19 while providing additional safeguards for other patients; and offering financial relief in the form of, for example, additional appropriations waiving patient cost-sharing, delaying payment reductions, and additional reimbursement.
For more information, please visit these areas: Government Contracts
Contact
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26
Webinar | 11.13.26
Leveraging the Power of Connection to Better Support our Well-Being
